Login Register Cart 0
Generic placeholder image

Reviews on Recent Clinical Trials

Editor-in-Chief

ISSN (Print): 1574-8871
ISSN (Online): 1876-1038

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Clinical Trial

Prevalence and Related Factors of Sarcopenia in Community-dwelling Elderly with Long-term Care Insurance

Author(s): Masahiro Kitamura, Kazuhiro P. Izawa*, Kodai Ishihara, Hiroaki Matsuda, Soichiro Okamura and Koji Fujioka

Volume 16, Issue 3, 2021

Published on: 11 February, 2021

Page: [335 - 340] Pages: 6

DOI: 10.2174/1574887116666210211144446

Price: $65

Open Access Journals Promotions 2
Abstract

Background and Objective: The purpose of this investigation was to examine the prevalence, related factors, and cut-off value of body mass index for sarcopenia in community-dwelling elderly covered by long-term care insurance.

Methods: Design was a cross-sectional study, in which113 consecutive community-dwelling elderly with long-term care insurance who underwent rehabilitation at a daycare center in Japan from January 2016 to January 2018, those who were aged ≥65 years old and could walk were included. Those in whom skeletal muscle mass index could not be measured were excluded. The determination of sarcopenia was made according to the criteria of the Asian Working Group for Sarcopenia. We analyzed the data with the unpaired t-test, χ2 test, logistic regression analysis, and receiver operating characteristic curves.

Results: The 99 elderly meeting the criteria were included and divided into the sarcopenia group (n=36) and no sarcopenia group (n=63). The prevalence was 36.4%. The sarcopenia group was significantly older and had lower body mass index, skeletal muscle mass index, and grip strength than the group without sarcopenia (p <0.05). Age and body mass index were extracted as significant sarcopenia- related factors (p <0.05). The cut-off value of body mass index for sarcopenia was 22.6 kg/m2.

Conclusion: The prevalence of sarcopenia in the elderly in the long-term care insurance region was 36.4%, and age and body mass index were extracted as sarcopenia-related factors. The cut-off value of body mass index for sarcopenia was 22.6 kg/m2.

Keywords: Sarcopenia, long-term care insurance, elderly, prevalence, body mass index, Japan.

« Previous
Graphical Abstract

[1]
World Health Organization. World Health Statistics 2018.
[2]
Cabinet Office Japan Annual Report on the Aging Society: 2017.
[3]
National Institute of Population and Society Research.. Population projections for Japan: 2016-2065.
[4]
Ministry of Health, Labour and Welfare. Long-term care, health and welfare services for the elderly 2017.
[5]
Fukuda Y, Nakao H, Yahata Y, Imai H. In-depth descriptive analysis of trends in prevalence of long-term care in Japan. Geriatr Gerontol Int 2008; 8(3): 166-71.
[http://dx.doi.org/10.1111/j.1447-0594.2008.00466.x] [PMID: 18822000]
[6]
Comas−Herrera A, Wittenberg R, Costa-Font J, et al. Future long-term care expenditure in Germany, Spain, Italy and the United Kingdom. Ageing Soc 2006; 26: 285-302.
[http://dx.doi.org/10.1017/S0144686X05004289]
[7]
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39(4): 412-23.
[http://dx.doi.org/10.1093/ageing/afq034] [PMID: 20392703]
[8]
Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014; 15(2): 95-101.
[http://dx.doi.org/10.1016/j.jamda.2013.11.025] [PMID: 24461239]
[9]
Morley JE, Anker SD, von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J Cachexia Sarcopenia Muscle 2014; 5(4): 253-9.
[http://dx.doi.org/10.1007/s13539-014-0161-y] [PMID: 25425503]
[10]
Yamada M, Nishiguchi S, Fukutani N, et al. Prevalence of sarcopenia in community-dwelling Japanese older adults. J Am Med Dir Assoc 2013; 14(12): 911-5.
[http://dx.doi.org/10.1016/j.jamda.2013.08.015] [PMID: 24094646]
[11]
Shimokata H, Ando F. Long-term longitudinal epidemiological study of frailty and sarcopenia. Jpn J Phys Fitness Sports Med 2017; 66: 133-42.
[http://dx.doi.org/10.7600/jspfsm.66.133]
[12]
Bastiaanse LP, Hilgenkamp TI, Echteld MA, Evenhuis HM. Prevalence and associated factors of sarcopenia in older adults with intellectual disabilities. Res Dev Disabil 2012; 33(6): 2004-12.
[http://dx.doi.org/10.1016/j.ridd.2012.06.002] [PMID: 22750356]
[13]
Nasimi N, Dabbaghmanesh MH, Sohrabi Z. Nutritional status and body fat mass: Determinants of sarcopenia in community-dwelling older adults. Exp Gerontol 2019; 122: 67-73.
[http://dx.doi.org/10.1016/j.exger.2019.04.009] [PMID: 31022445]
[14]
Kang YJ, Yoo JI, Ha YC. Sarcopenia feature selection and risk prediction using machine learning: A cross-sectional study. Medicine (Baltimore) 2019; 98(43): e17699.
[http://dx.doi.org/10.1097/MD.0000000000017699] [PMID: 31651901]
[15]
Figueiredo CP, Domiciano DS, Lopes JB, et al. Prevalence of sarcopenia and associated risk factors by two diagnostic criteria in community-dwelling older men: the São Paulo Ageing & Health Study (SPAH). Osteoporos Int 2014; 25(2): 589-96.
[http://dx.doi.org/10.1007/s00198-013-2455-x] [PMID: 23892584]
[16]
Landi F, Liperoti R, Russo A, et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 2012; 31(5): 652-8.
[http://dx.doi.org/10.1016/j.clnu.2012.02.007] [PMID: 22414775]
[17]
Gariballa S, Alessa A. Sarcopenia: prevalence and prognostic significance in hospitalized patients. Clin Nutr 2013; 32(5): 772-6.
[http://dx.doi.org/10.1016/j.clnu.2013.01.010] [PMID: 23395102]
[18]
Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr 2014; 68(9): 1001-7.
[http://dx.doi.org/10.1038/ejcn.2014.117] [PMID: 24961545]
[19]
Tsutsui T, Muramatsu N. Care-Needs Certification in the Long-Term Care Insurance System of Japan. J Am Geriatr Soc 2005; 53: 522-7.
[20]
Ikegami N. Rationale, design and sustainability of long-term care insurance in Japan-in retrospect. Soc Policy Soc 2007; 6: 423-34.
[http://dx.doi.org/10.1017/S1474746407003739]
[21]
Sawaya Y, Ishizaka M, Kubo A, et al. Prevalence and features of sarcopenia in older adults undergoing day-care rehabilitation. Rigakuryoho Kagaku 2019; 34: 111-4.
[http://dx.doi.org/10.1589/rika.34.111]
[22]
Kamo T, Suzuki R, Ito K, Sugimoto T, Murakoshi T. Prevalence of sarcopenia and its relation to body composition, physiological function, and nutritional status in community-dwelling frai1 elderly people. J Jpn Phys Ther Assoc 2013; 40: 414-20.
[23]
Kawada K, Tsukamoto T, Washizu G, Uchida M, Isozaki K. Skeletal muscle mass and physical and cognitive function in community-dwelling elderly adults: comparisons between diagnostic algorithm-classified sarcopenia and non-sarcopenia. Research reports of Faculty of Health Sciences. Tokoha University 2018; 5: 31-7.
[24]
Tanimoto Y, Watanabe M, Sugiura Y, Hayashida I, Kusabiraki T, Kono K. [Factors related to sarcopenia in community-dwelling elderly subjects in Japan]. Nippon Koshu Eisei Zasshi 2013; 60(11): 683-90.
[PMID: 24418916]
[25]
Uemura K, Makizako H, Lee S, et al. The impact of sarcopenia on incident homebound status among community-dwelling older adults: A prospective cohort study. Maturitas 2018; 113: 26-31.
[http://dx.doi.org/10.1016/j.maturitas.2018.03.007] [PMID: 29903645]
[26]
Kamo T, Ishii H, Suzuki K, Nishida Y. Prevalence of sarcopenia and its association with activities of daily living among japanese nursing home residents. Geriatr Nurs 2018; 39(5): 528-33.
[http://dx.doi.org/10.1016/j.gerinurse.2018.02.011] [PMID: 29555099]
[27]
Keogh JW, Senior H, Beller EM, Henwood T. Prevalence and risk factors for low habitual walking speed in nursing home residents: an observational study. Arch Phys Med Rehabil 2015; 96(11): 1993-9.
[http://dx.doi.org/10.1016/j.apmr.2015.06.021] [PMID: 26210000]
[28]
Shen Y, Chen J, Chen X, Hou L, Lin X, Yang M. Prevalence and associated factors of sarcopenia in nursing home residents: a systematic review and meta-analysis. J Am Med Dir Assoc 2019; 20(1): 5-13.
[http://dx.doi.org/10.1016/j.jamda.2018.09.012] [PMID: 30409494]
[29]
Müller MJ, Braun W, Enderle J, Bosy-Westphal A. Beyond BMI: Conceptual issues related to overweight and obese patients. Obes Facts 2016; 9(3): 193-205.
[http://dx.doi.org/10.1159/000445380] [PMID: 27286962]
[30]
Zhang Z, Pereira SL, Luo M, Matheson EM. Evaluation of blood biomarkers associated with risk of malnutrition in older adults: a systematic review and meta-analysis. Nutrients 2017; 9(8): 829.
[http://dx.doi.org/10.3390/nu9080829] [PMID: 28771192]
[31]
Centre for Public Health Excellence at NICE (UK); National Collaborating Centre for Primary Care (UK). Obesity: The Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children. London: National Institute for Health and Clinical Excellence (UK) 2006.
[32]
Ministry of Health, Labor and Welfare, Dietary Reference Intakes for Japanese. 2015.
[33]
Komai S, Watanabe Y, Fujiwara Y, et al. Association between the nutritional status and the severity of sarcopenia among community-dwelling elderly Japanese people. Nippon Ronen Igakkai Zasshi 2016; 53(4): 387-95.
[http://dx.doi.org/10.3143/geriatrics.53.387] [PMID: 27885226]
[34]
Konagaya Y, Watanabe T. Evaluation of multimodal factors for the certification of long-term care insurance among community-dwelling elderly: a four-year follow-up study. Nippon Ronen Igakkai Zasshi 2014; 51(2): 170-7. [Jpanese with English abstract].
[http://dx.doi.org/10.3143/geriatrics.51.170] [PMID: 24858121]
[35]
Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 2008; 18(5): 388-95.
[http://dx.doi.org/10.1016/j.numecd.2007.10.002] [PMID: 18395429]
[36]
Htun NC, Ishikawa-Takata K, Kuroda A, et al. Screening for malnutrition in community dwelling older Japanese: preliminary development and evaluation of the Japanese Nutritional Risk Screening Tool (NRST). J Nutr Health Aging 2016; 20(2): 114-20.
[http://dx.doi.org/10.1007/s12603-015-0555-3] [PMID: 26812506]
[37]
Lozano-Montoya I, Correa-Pérez A, Abraha I, et al. Nonpharmacological interventions to treat physical frailty and sarcopenia in older patients: a systematic overview - the SENATOR Project ONTOP Series. Clin Interv Aging 2017; 12: 721-40.
[http://dx.doi.org/10.2147/CIA.S132496] [PMID: 28490866]
[38]
Mori H, Tokuda Y. Effect of whey protein supplementation after resistance exercise on the muscle mass and physical function of healthy older women: A randomized controlled trial. Geriatr Gerontol Int 2018; 18(9): 1398-404.
[http://dx.doi.org/10.1111/ggi.13499] [PMID: 30113122]

Rights & Permissions Print Cite
Article Metrics
13
Wayfinder Image
Open Access Journals Promotions
© 2024 Bentham Science Publishers | Privacy Policy